Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

BACKGROUND/AIMS: Prospective data on switching anti-vascular endothelial growth factors in patients with neovascular age-related macular degeneration (nAMD) who have previously shown no/partial response are limited. This prospective study assessed the effect of switching from aflibercept to ranibizu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Ophthalmol
Autors principals: Gale, Richard P, Pearce, Ian, Eter, Nicole, Ghanchi, Faruque, Holz, Frank G, Schmitz-Valckenberg, Steffen, Balaskas, Konstantinos, Burton, Ben J L, Downes, Susan M, Eleftheriadis, Haralabos, George, Sheena, Gilmour, David, Hamilton, Robin, Lotery, Andrew J, Patel, Nishal, Prakash, Priya, Santiago, Cynthia, Thomas, Saju, Varma, Deepali, Walters, Gavin, Williams, Michael, Wolf, Armin, Zakri, Rosina H, Igwe, Franklin, Ayan, Filis
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Clinical Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7147176/
https://ncbi.nlm.nih.gov/pubmed/31383649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2019-314251
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars